Health

Moderna's Flu Vaccine Approved for Adults Aged 50 and Up

Updated 2026-08-06 18:25 UTC 1 source Neutral

The FDA has approved Moderna’s new mRNA flu vaccine, mFLUSIVA, for all adults ages 50 and up. The approval comes after a rollercoaster review process.

Coverage timeline — 1 article

Ars Technica

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

2026-08-06 16:31 UTC